“As humans age, errors occur with increasing frequency in our nerve cells,” explains Janine Kirstein from the University of Bremen. “In Alzheimer’s disease, for example, there is a growing accumulation of misfolded proteins, which then clump together and form elongated, rope-like structures (fibrillar Aβ aggregates).” These ‘rope-like structures’ can affect large areas of the brain and ultimately lead to diseases such as Alzheimer’s or Parkinson’s – and, in the worst-case scenario, to dementia with all the associated cognitive impairments.
Her research group has now succeeded in visualising this process and, above all, in identifying the ‘starting point’ of the disease – the ‘nerve cell 0’ – in nematodes.
Using this disease model, they were able to show that the aggregation of the Abeta peptide begins in exactly six nerve cells – the IL2 neurons – and systematically spreads from there to all nerve cells. They also demonstrated that specifically inhibiting Abeta aggregation in the IL2 neurons slows down the aggregation cascade and its spread to other neurons. Furthermore, a reduction in toxicity and an increase in median lifespan were observed in the nematodes.
The findings from this research now make it possible to focus specifically on the nerve cells in humans where neurodegenerative diseases such as Alzheimer’s begin. “One could, for example, develop a marker that would allow us to determine whether degeneration has already begun,” said Kirstein. “This would enable us to act more quickly to prevent further consequences.” These findings are therefore highly relevant both for diagnostics and for the development of new therapeutic approaches.
Reference:
University of Bremen
. Novel amyloid-beta pathology C. elegans model reveals distinct neurons as seeds of pathogenicity, Progress in Neurobiology 2021; https://www.sciencedirect.com/science/article/pii/S0301008220301623